Las Vegas, NV -- (SBWIRE) -- 01/29/2014 -- - EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.EquityObserver.com issues a special report on the following stocks: Chelsea Therapeutics International Ltd (NASDAQ:CHTP), Bitauto Hldg Ltd (ADR) (NYSE:BITA), Vonage Holdings Corp (NYSE:VG), VIVUS, Inc (NASDAQ:VVUS)
Chelsea Therapeutics International Ltd (NASDAQ:CHTP) opened the session at $4.40 and closed at $4.50. The stock showed a positive performance of 2.51% in the last trading session. The stock traded on a volume of 2.39 million shares and the average volume of the stock remained 5.86 million shares. Chelsea Therapeutics International, Ltd. is a development stage pharmaceutical company that focuses on acquiring, developing and commercializing products for the treatment of a variety of human diseases. The Company is developing a therapeutic agent for the treatment of symptomatic neurogenic orthostatic hypotension (NOH), associated with primary autonomic failure and falls related to NOH in Parkinson’s Disease (PD),
Will CHTP Continue To Move Higher? Find Out Here
Bitauto Hldg Ltd (ADR) (NYSE:BITA) traded 2.34 million shares in the last business day while the average volume of the stock remained 1.46 million shares. The 52 week range of the stock remained $7.06 - $39.84. The stock showed a positive movement of 8.89% to end at $31.22. Bitauto Holdings Limited (Bitauto) is a provider of Internet content and marketing services. The Company’s bitauto.com and taoche.com websites provide consumers with up-to-date new and used automobile pricing information, specifications.
For How Long BITA will fight for Profitability? Read This Trend Analysis report
Vonage Holdings Corp (NYSE:VG) reported 2.31 million shares were exchanged during the last trade, while the average volume is about 1.78 million shares. The stock escalated 4.34% and finished the day at $4.57. Vonage Holdings Corp. (Vonage) is a provider of communications services connecting people through broadband devices worldwide. The Company’s network include session initiation protocol (SIP) based voice over Internet protocol (VoIP), network on the Internet.
Why Should Investors Buy VG After The Recent Gain? Just Go Here and Find Out
VIVUS, Inc (NASDAQ:VVUS) the stock decreased -2.27% and finished the session at $7.75. Traded with volume of 2.31 million shares in the prior session and the average volume of the stock remained 1.99 million shares. VIVUS, Inc. is a biopharmaceutical company. It commercializes and develops therapies to address unmet needs in obesity, sleep apnea, diabetes and sexual health. Its drug, Qsymia (phentermine and topiramate extended-release) was approved by the the United States Food and Drug Administration (FDA).
Will VVUS Get Buyers Even After The Recent Rally? Find Out Here
About Equity Observer:
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/ employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/disclaimer-2/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)